Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Other Non-Current Assets (2020 - 2026)

RxSight filings provide 6 years of Other Non-Current Assets readings, the most recent being $590000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 63.89% to $590000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $590000.0, a 63.89% increase, with the full-year FY2025 number at $590000.0, up 63.89% from a year prior.
  • Other Non-Current Assets hit $590000.0 in Q4 2025 for RxSight, up from $536000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $811000.0 in Q4 2021 to a low of $132000.0 in Q1 2022.
  • Median Other Non-Current Assets over the past 5 years was $590000.0 (2025), compared with a mean of $546105.3.
  • Biggest five-year swings in Other Non-Current Assets: soared 637.27% in 2021 and later plummeted 80.68% in 2023.
  • RxSight's Other Non-Current Assets stood at $811000.0 in 2021, then fell by 6.17% to $761000.0 in 2022, then plummeted by 80.68% to $147000.0 in 2023, then surged by 144.9% to $360000.0 in 2024, then soared by 63.89% to $590000.0 in 2025.
  • The last three reported values for Other Non-Current Assets were $590000.0 (Q4 2025), $536000.0 (Q3 2025), and $750000.0 (Q2 2025) per Business Quant data.